Given the heterogeneous expression of the IFN signaling cluster (cluster 1) within COVID-19 samples, we further compared the expression of type I–specific (ISG-I) and type II–specific IFN-stimulated genes (ISG-II) between COVID-19+ cases and healthy controls and within COVID-19+ cases of varying severity. The gene discussed is IFNA1; the disease is COVID-19.